{"id":45397,"date":"2026-04-24T08:20:15","date_gmt":"2026-04-24T08:20:15","guid":{"rendered":"https:\/\/www.vtmarkets.com\/tr\/uncategorized\/eli-lilly-hareket-halindeki-ilac-devi\/"},"modified":"2026-04-24T08:20:15","modified_gmt":"2026-04-24T08:20:15","slug":"eli-lilly-hareket-halindeki-ilac-devi","status":"publish","type":"post","link":"https:\/\/www.vtmarkets.com\/tr-mena\/featured\/eli-lilly-hareket-halindeki-ilac-devi\/","title":{"rendered":"Eli Lilly: Hareket Halindeki \u0130la\u00e7 Devi"},"content":{"rendered":"\n<figure class=\"wp-block-image size-large\"><a href=\"https:\/\/www.vtmarkets.com\/cfd-shares\/?utm_source=Opinion&amp;rt=Biotech-LLY\" target=\"_blank\" rel=\" noreferrer noopener\"><img decoding=\"async\" src=\"https:\/\/www.vtmarkets.com\/tr-mena\/wp-content\/uploads\/sites\/9\/2026\/05\/ELILLY-1024x573.webp\" alt=\"\" class=\"wp-image-48570\"\/><\/a><figcaption>Eli Lilly (LLY), VT Markets\u2019te CFD olarak i\u015flem g\u00f6rebilir.<\/figcaption><\/figure>\n\n\n\n<hr class=\"wp-block-separator has-alpha-channel-opacity\"\/>\n\n\n\n<p>Jeopolitik belirsizlikler ve de\u011fi\u015fen ekonomik ko\u015fullar\u0131n tetikledi\u011fi k\u00fcresel piyasa oynakl\u0131\u011f\u0131nda (fiyatlar\u0131n h\u0131zl\u0131 ini\u015f-\u00e7\u0131k\u0131\u015f yapmas\u0131), yat\u0131r\u0131mc\u0131lar portf\u00f6ylerinde daha isabetli kararlar ar\u0131yor. 2026\u2019da <a href=\"https:\/\/www.vtmarkets.com\/learn\/is-golds-2026-rally-just-getting-started\/?utm_source=Opinion&amp;rt=Biotech-LLY\" target=\"_blank\" rel=\"noopener\" title=\"\">Alt\u0131n y\u00fckselirken<\/a>, ila\u00e7 sekt\u00f6r\u00fc de \u00f6ne \u00e7\u0131k\u0131yor; Eli Lilly yak\u0131ndan izlenmesi gereken \u015firketlerden biri. \u015eirket yeni \u00fcr\u00fcn lansmanlar\u0131 (piyasaya yeni ila\u00e7 s\u00fcrme) ve son sat\u0131n almalarla b\u00fcy\u00fcrken, artan rekabet ve hukuki s\u00fcre\u00e7lerle de kar\u015f\u0131 kar\u015f\u0131ya.<\/p>\n\n\n\n<p>CFD (fark s\u00f6zle\u015fmesi: varl\u0131\u011f\u0131n kendisini almadan, fiyat de\u011fi\u015fimi \u00fczerinden i\u015flem) yapanlar i\u00e7in Eli Lilly; de\u011feri artan <a href=\"https:\/\/www.vtmarkets.com\/opinion\/a-reliable-sector-in-volatile-times-pharmaceutical-icons-like-gsk\/?utm_source=Opinion&amp;rt=Biotech-LLY\" target=\"_blank\" rel=\"noopener\" title=\"\">di\u011fer ila\u00e7 hisseleri<\/a> gibi, sekt\u00f6rdeki dalgalanmay\u0131 y\u00f6netmek ve portf\u00f6y\u00fc \u00e7e\u015fitlendirmek i\u00e7in bir f\u0131rsat sunabilir.<\/p>\n\n\n\n<h3 class=\"wp-block-heading\"><strong>Eli Lilly\u2019nin Rekabet Konumu<\/strong> &#8211; <strong>Birden Fazla Cephede M\u00fccadele<\/strong><\/h3>\n\n\n\n<h2 class=\"wp-block-heading\"><strong>GLP-1 \u0130la\u00e7 Pazar\u0131nda G\u00fc\u00e7l\u00fc Konum<\/strong><\/h2>\n\n\n\n<p>Eli Lilly\u2019nin <a href=\"https:\/\/www.cnbc.com\/2026\/04\/01\/eli-lilly-glp-1-pill-foundayo-approved-for-obesity.html\" target=\"_blank\" rel=\"noopener nofollow\" title=\"\">GLP\u20111 ila\u00e7 pazar\u0131ndaki g\u00fc\u00e7l\u00fc konumu b\u00fcy\u00fcmenin ana itici g\u00fcc\u00fc oldu<\/a>. GLP\u20111, obezite ve diyabette kullan\u0131lan bir ila\u00e7 s\u0131n\u0131f\u0131 (i\u015ftah\u0131 ve kan \u015fekerini d\u00fczenlemeye yard\u0131mc\u0131 olur). Tirzepatid gibi \u00fcr\u00fcnler yayg\u0131n \u015fekilde re\u00e7ete ediliyor ve y\u00fcksek gelir \u00fcretmeye devam etmesi bekleniyor. Ancak Amazon\u2019un ila\u00e7 da\u011f\u0131t\u0131m\u0131na girmesi bu alanda yeni bir rekabet yarat\u0131yor.<\/p>\n\n\n\n<p>Amazon\u2019un geleneksel sekt\u00f6rleri de\u011fi\u015ftirme g\u00fcc\u00fc, fiyatlar\u0131n d\u00fc\u015fmesine ve yeni da\u011f\u0131t\u0131m modellerine yol a\u00e7abilir. Amazon\u2019un bu hamlesi, Lilly\u2019nin GLP\u20111\u2019deki \u201cfiyatlama g\u00fcc\u00fcn\u00fc\u201d (fiyatlar\u0131 belirleyebilme kapasitesi) zay\u0131flatabilir. Amazon maliyetleri d\u00fc\u015f\u00fcr\u00fcr veya da\u011f\u0131t\u0131m\u0131 de\u011fi\u015ftirirse, Lilly hissesi bask\u0131 g\u00f6rebilir.<\/p>\n\n\n\n<h3 class=\"wp-block-heading\">Sekt\u00f6re Etkisi<\/h3>\n\n\n\n<p><strong>GLP\u20111 Oyuncular\u0131 \u0130\u00e7in Rekabet Bask\u0131s\u0131:<\/strong> Eli Lilly, yaln\u0131zca klasik ila\u00e7 \u015firketleriyle de\u011fil, <a href=\"https:\/\/www.wsj.com\/health\/pharma\/amazon-com-to-offer-program-for-glp-1-weight-loss-drugs-72465385\" target=\"_blank\" rel=\"noopener nofollow\" title=\"\">Amazon\u2019un fiyatlama ve da\u011f\u0131t\u0131m stratejileriyle<\/a> de daha sert rekabet edebilir. Bu durum k\u00e2r marjlar\u0131n\u0131 (sat\u0131\u015ftan kalan k\u00e2r oran\u0131) ve uzun vadeli b\u00fcy\u00fcmeyi etkileyebilir.<\/p>\n\n\n\n<p><strong>K\u00fc\u00e7\u00fck Biyoteknoloji \u015eirketlerine Dolayl\u0131 Etki:<\/strong> BioMarine gibi GLP\u20111\u2019de do\u011frudan olmayan \u015firketler hemen etkilenmeyebilir. Ancak ila\u00e7 sekt\u00f6r\u00fcnde yat\u0131r\u0131mc\u0131 alg\u0131s\u0131, Eli Lilly gibi b\u00fcy\u00fck oyuncular\u0131n hareketlerinden etkilenir. Lilly\u2019deki bir y\u00f6n de\u011fi\u015fimi, k\u00fc\u00e7\u00fck biyoteknoloji \u015firketlerinin hisselerini de etkileyebilir.<\/p>\n\n\n\n<hr class=\"wp-block-separator has-alpha-channel-opacity\"\/>\n\n\n\n<h2 class=\"wp-block-heading\"><strong>Daha Geni\u015f Portf\u00f6y \u0130\u00e7in Stratejik M&amp;A Hamleleri<\/strong><\/h2>\n\n\n\n<p>Amazon rekabet olu\u015ftururken, Eli Lilly uzun vadeli b\u00fcy\u00fcmeyi sat\u0131n almalarla destekliyor. \u015eirketin <a href=\"https:\/\/simplywall.st\/stocks\/us\/pharmaceuticals-biotech\/nyse-lly\/eli-lilly\/news\/eli-lillys-us7b-kelonia-deal-expands-oncology-and-valuation\" target=\"_blank\" rel=\"noopener nofollow\" title=\"\">Kelonia Therapeutics\u2019i 7 milyar dolara sat\u0131n almas\u0131<\/a>, Lilly\u2019yi onkolojiye (kanser tedavileri) ve h\u00fccre tedavisine (hastal\u0131\u011f\u0131 hedefleyen canl\u0131 h\u00fccre temelli tedaviler) daha fazla ta\u015f\u0131yor ve yeni b\u00fcy\u00fcme alanlar\u0131 a\u00e7\u0131yor. M&amp;A, \u201cbirle\u015fme ve sat\u0131n alma\u201d demektir.<\/p>\n\n\n\n<p>Anla\u015fma, Lilly\u2019nin h\u0131zl\u0131 b\u00fcy\u00fcyen tedavi alanlar\u0131ndaki varl\u0131\u011f\u0131n\u0131 art\u0131r\u0131yor ve \u015firketi sekt\u00f6r\u00fcn en dinamik alanlar\u0131ndan birinde daha g\u00fc\u00e7l\u00fc konumluyor.<\/p>\n\n\n\n<h3 class=\"wp-block-heading\">Sekt\u00f6r \u0130\u00e7in Anlam\u0131<\/h3>\n\n\n\n<p>Lilly\u2019nin onkolojiye a\u011f\u0131rl\u0131k vermesi, biyoteknolojide Ar\u2011Ge rekabetini (ara\u015ft\u0131rma-geli\u015ftirme yar\u0131\u015f\u0131n\u0131) art\u0131r\u0131yor. Vertex Pharmaceuticals gibi \u015firketler, b\u00fcy\u00fck oyuncular\u0131n \u00fcr\u00fcn hatt\u0131n\u0131 (yeni ila\u00e7 adaylar\u0131 havuzu\/pipeline) geni\u015fletmesiyle daha fazla bask\u0131 hissedebilir. Yat\u0131r\u0131mc\u0131 ilgisi \u00f6l\u00e7ek ve \u00e7e\u015fitlili\u011fe kayd\u0131k\u00e7a, k\u00fc\u00e7\u00fck biyoteknoloji \u015firketlerinin de\u011ferlemeleri (piyasadaki fiyat\/\u015firket de\u011feri) bask\u0131lanabilir.<\/p>\n\n\n\n<hr class=\"wp-block-separator has-alpha-channel-opacity\"\/>\n\n\n\n<h2 class=\"wp-block-heading\"><strong>Hukuki Geli\u015fmeler: Olas\u0131 Bir Engel<\/strong><\/h2>\n\n\n\n<p>Eli Lilly\u2019nin g\u00fcndeminde hukuki riskler de var. Son mahkeme karar\u0131, Teva Pharmaceutical Industries\u2019in Lilly\u2019nin migren ilac\u0131 patentleriyle ilgili <a href=\"https:\/\/www.reuters.com\/legal\/litigation\/us-appeals-court-revives-teva-lawsuit-against-eli-lilly-over-migraine-drug-2026-04-16\" target=\"_blank\" rel=\"noopener nofollow\" title=\"\">patent davas\u0131n\u0131 yeniden canland\u0131rd\u0131<\/a>. Patent, bir ilac\u0131n belirli bir s\u00fcreyle yasal korumas\u0131d\u0131r. Bu dava hemen b\u00fcy\u00fck bir etki yaratmayabilir; ancak belirsizlik ekler.<\/p>\n\n\n\n<p>Teva\u2019n\u0131n iddialar\u0131n\u0131n g\u00fc\u00e7lenmesi, Lilly\u2019nin migren \u00fcr\u00fcnlerinden elde etti\u011fi geliri etkileyebilir. B\u00f6yle bir senaryoda Lilly, uzla\u015fmaya gidebilir (anla\u015farak davay\u0131 bitirme) veya \u00fcr\u00fcn stratejisini de\u011fi\u015ftirebilir.<\/p>\n\n\n\n<h3 class=\"wp-block-heading\">Yat\u0131r\u0131mc\u0131lar \u0130\u00e7in Anlam\u0131<\/h3>\n\n\n\n<p>\u0130\u015flem yapanlar i\u00e7in, hukuki belirsizlik zaten dalgal\u0131 bir hisseye ek risk getirir. Sonu\u00e7 net de\u011fil; ancak \u00f6nemli bir hukuki geli\u015fme Lilly\u2019nin piyasadaki konumunu etkileyebilece\u011fi i\u00e7in izlenmeli.<\/p>\n\n\n\n<!-- TradingView Widget BEGIN --><div class=\"tradingview-widget-container\">  <div class=\"tradingview-widget-container__widget\"><\/div>  <div class=\"tradingview-widget-copyright\"><a href=\"www.vtmarkets.com\/trade-now\/?utm_source=Opinion&#038;rt=Biotech-LLY\" rel=\"noopener nofollow\" target=\"_blank\"><span class=\"blue-text\">Markets today<\/span><\/a><span class=\"trademark\"> Assets available on VT, by TradingView<\/span><\/div>  <script type=\"text\/javascript\" src=\"https:\/\/s3.tradingview.com\/external-embedding\/embed-widget-tickers.js\" async>  {  \"symbols\": [    {      \"proName\": \"NYSE:LLY\",      \"title\": \"Eli Lilly & Co\"    },    {      \"proName\": \"NASDAQ:BMRN\",      \"title\": \"BioMarin Pharmaceutical Inc\"    },    {      \"proName\": \"NASDAQ:VRTX\",      \"title\": \"Vertex Pharmaceuticals Inc\"    }  ],  \"colorTheme\": \"dark\",  \"locale\": \"en\",  \"largeChartUrl\": \"\",  \"isTransparent\": false,  \"showSymbolLogo\": true}  <\/script><\/div><!-- TradingView Widget END -->\n\n\n\n<p><\/p>\n\n\n\n<h2 class=\"wp-block-heading\"><strong>\u0130la\u00e7 sekt\u00f6r\u00fcnde oynakl\u0131k artar m\u0131?<\/strong><\/h2>\n\n\n\n<p>Lilly\u2019nin performans\u0131, geni\u015f ila\u00e7 piyasas\u0131n\u0131 belirgin \u015fekilde etkiler. Sekt\u00f6r liderlerinden biri oldu\u011fu i\u00e7in, hisse hareketleri biyoteknoloji taraf\u0131nda yat\u0131r\u0131mc\u0131 alg\u0131s\u0131n\u0131 y\u00f6nlendirir. Lilly iyi giderse, \u00e7o\u011fu zaman sekt\u00f6r geneli de destek bulur. Kritik soru, Lilly\u2019nin bu sars\u0131nt\u0131lara ra\u011fmen liderli\u011fini koruyup koruyamayaca\u011f\u0131 ve biyoteknolojiye girmek isteyenler i\u00e7in h\u00e2l\u00e2 b\u00fcy\u00fcme potansiyeli ta\u015f\u0131y\u0131p ta\u015f\u0131mad\u0131\u011f\u0131.<\/p>\n\n\n\n<p>Genel piyasa h\u00e2l\u00e2 enflasyon, tedarik zinciri sorunlar\u0131 ve di\u011fer ekonomik etkenlerle u\u011fra\u015f\u0131yor. Tedarik zinciri, \u00fcretimden teslimata kadar olan mal ak\u0131\u015f\u0131d\u0131r. Bu ba\u015fl\u0131klar Lilly dahil t\u00fcm \u015firketleri etkiler. \u00d6nemli ekonomik de\u011fi\u015fimlere dair geli\u015fmeler i\u00e7in <a href=\"https:\/\/www.vtmarkets.com\/week_ahead\/?utmsource=Opinion\" target=\"_blank\" rel=\"noopener\" title=\"\">haftal\u0131k piyasa g\u00f6r\u00fcn\u00fcm\u00fc<\/a> i\u00e7eriklerimizi takip edebilirsiniz.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\"><strong>Biyoteknoloji hisselerine giri\u015f<\/strong><\/h2>\n\n\n\n<p>\u0130la\u00e7 sekt\u00f6r\u00fcne yeni girenler i\u00e7in Eli Lilly hem f\u0131rsat hem risk bar\u0131nd\u0131r\u0131r. \u015eu ba\u015fl\u0131klar izlenmeli:<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>D\u00fczenleyici De\u011fi\u015fiklikler<\/strong>: Medicare gibi geri \u00f6deme kurallar\u0131 (devletin sa\u011fl\u0131k harcamas\u0131 kapsam\u0131) veya FDA onaylar\u0131 (ABD ila\u00e7 otoritesinin ruhsat kararlar\u0131) Lilly\u2019nin konumunu etkileyebilir.<\/li>\n\n\n\n<li><strong>Amazon Hamleleri<\/strong>: Bu yeni rekabetin hissede k\u0131sa vadeli fiyatlamaya etkisi yak\u0131ndan izlenmeli.<\/li>\n\n\n\n<li><strong>M&amp;A (Birle\u015fme ve Sat\u0131n Alma)<\/strong>: Sat\u0131n alma s\u00fcrecinin devam\u0131 ve \u015firketin \u00fcr\u00fcn hatt\u0131n\u0131 geni\u015fletme planlar\u0131 takip edilmeli; sermayeyi daha geni\u015f \u00fcr\u00fcn hatt\u0131na sahip b\u00fcy\u00fck ila\u00e7 \u015firketlerine kayd\u0131rma se\u00e7ene\u011fi de\u011ferlendirilebilir.<\/li>\n\n\n\n<li><strong>Hukuki Riskler<\/strong>: Dava s\u00fcre\u00e7lerinin sonucu, hisse y\u00f6n\u00fcn\u00fc ve rakip hisselerdeki hareketleri etkileyebilir.<\/li>\n<\/ul>\n\n\n\n<p>\u00d6n\u00fcm\u00fczdeki aylar, Lilly\u2019nin liderli\u011fini koruyup koruyamayaca\u011f\u0131n\u0131 g\u00f6sterecek. \u015eirketin rekabete, d\u00fczenleyici de\u011fi\u015fikliklere ve hukuki geli\u015fmelere tepkisi, performans\u0131 \u015fekillendirecek.<\/p>\n\n\n\n<hr class=\"wp-block-separator has-alpha-channel-opacity\"\/>\n\n\n\n<p><strong><a href=\"http:\/\/vtmarkets.com\/?utm_source=Opinion&amp;rt=Biotech-LLY\" target=\"_blank\" rel=\"noopener\" title=\"\">VT Markets<\/a><\/strong> \u00fczerinden LLY ve GSK, VRTX gibi biyoteknoloji\/ila\u00e7 hisselerinde CFD fiyat hareketlerini anl\u0131k izleyebilirsiniz.<br><\/p>\n\n<p>\n\n<p><strong>Hemen i\u015flem yapmaya ba\u015flay\u0131n &#8211; Ger\u00e7ek VT Markets hesab\u0131n\u0131z\u0131 olu\u015fturmak i\u00e7in <a href=\"https:\/\/www.vtmarkets.com\/tr\/trade-now\/\">buraya<\/a> t\u0131klay\u0131n <\/strong> <\/p>\n<!-- \/wp:post-content -->","protected":false},"excerpt":{"rendered":"<p>G\u00f6zler Eli Lilly\u2019de: GLP-1\u2019de g\u00fc\u00e7l\u00fc b\u00fcy\u00fcme s\u00fcrerken Amazon\u2019un da\u011f\u0131t\u0131m hamlesi marjlar\u0131 s\u0131k\u0131\u015ft\u0131rabilir. 7 milyar dolarl\u0131k Kelonia al\u0131m\u0131 \u00e7e\u015fitlendiriyor; Teva patent davas\u0131 belirsizlik yarat\u0131yor, sekt\u00f6r etkilenebilir.<\/p>\n","protected":false},"author":87,"featured_media":45396,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[48,49],"tags":[],"class_list":["post-45397","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-featured","category-opinion"],"acf":{"acf_article_selection_author":null},"aioseo_notices":[],"_links":{"self":[{"href":"https:\/\/www.vtmarkets.com\/tr-mena\/wp-json\/wp\/v2\/posts\/45397","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.vtmarkets.com\/tr-mena\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.vtmarkets.com\/tr-mena\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.vtmarkets.com\/tr-mena\/wp-json\/wp\/v2\/users\/87"}],"replies":[{"embeddable":true,"href":"https:\/\/www.vtmarkets.com\/tr-mena\/wp-json\/wp\/v2\/comments?post=45397"}],"version-history":[{"count":0,"href":"https:\/\/www.vtmarkets.com\/tr-mena\/wp-json\/wp\/v2\/posts\/45397\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.vtmarkets.com\/tr-mena\/wp-json\/wp\/v2\/media\/45396"}],"wp:attachment":[{"href":"https:\/\/www.vtmarkets.com\/tr-mena\/wp-json\/wp\/v2\/media?parent=45397"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.vtmarkets.com\/tr-mena\/wp-json\/wp\/v2\/categories?post=45397"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.vtmarkets.com\/tr-mena\/wp-json\/wp\/v2\/tags?post=45397"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}